Alks 2680

6 trials 1 recruiting

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

1 Recruiting

3 Completed trials

1 Sponsors

6 Countries

Phase III

Phase II/III

Phase II

Phase III: 2 Phase II/III: 1 Phase II: 3

Indications tested

Sponsors using this IMP

Alkermes Inc. 6

All trials

6 total

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending

2025-523911-13-00 Phase III 5 countries Alkermes Inc.
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 Pending

2025-523912-35-00 Phase III 5 countries Alkermes Inc.
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia Recruiting

2024-519822-18-00 Phase II/III 6 countries Alkermes Inc.
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia Ended

2025-520981-23-00 Phase II 6 countries Alkermes Inc.
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2 Ended

2024-515452-20-00 Phase II 6 countries Alkermes Inc.
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 Ended

2024-511112-24-00 Phase II 6 countries Alkermes Inc.

Showing 1–6 of 6 trials

← All drugs A–Z